Point72 (DIFC)’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$14.7M Buy
109,658
+104,155
+1,893% +$12.7M 0.96% 25
2025
Q2
$684K Buy
+5,503
New +$700K 0.03% 496
2024
Q4
Sell
-21,686
Closed -$3.23M 1834
2024
Q3
$3.23M Buy
+21,686
New +$3.11M 0.11% 231

Other funds holding RGEN

Point72 (DIFC)'s RGEN Position: Q3 2025 in Review

Point72 (DIFC) increased its Repligen (RGEN) stake by 1,893% in Q3 2025, buying an estimated $12.7M and bringing the position to 109,658 shares worth $14.7M. The position accounts for 0.96% of the portfolio, ranked #25.

Point72 (DIFC) first reported a position in RGEN in Q3 2024 and has held it in 3 quarters since. 452 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Point72 (DIFC) held 109,658 shares of Repligen worth $14.7M as of Q3 2025.
  • Point72 (DIFC) bought 104,155 Repligen shares in Q3 2025, an estimated $12.7M.
  • Repligen made up 0.96% of Point72 (DIFC)'s portfolio in Q3 2025, its #25 holding.
  • Point72 (DIFC) first reported a position in Repligen in Q3 2024 and has held it in 3 quarters since.
  • 452 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.